{"id":"W2121607722","doi":"10.1093/annonc/mdj965","title":"Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer","year":2006,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":116,"is_retracted":true,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Eli Lilly and Company","keywords":"Medicine; Vinblastine; Gemcitabine; Internal medicine; Oncology; Hazard ratio; Bladder cancer; Cisplatin; Transitional cell carcinoma; Progression-free survival; Chemotherapy; Urology; Confidence interval; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":{"nature":"Retraction","reason":"Duplication of/in Article;","date":"11/1/2011 0:00","openalex_flagged":true},"screen":null}